Regeneron Pharmaceuticals

accelerated
Biotech

Regeneron, Sanofi receive 1- to 2-month priority review vouchers

The national priority vouchers position companies including Merck KGaA, Regeneron and Sanofi to complete the review process in one to two months.
Nick Paul Taylor Oct 17, 2025 8:30am
hearing audio waves

Regeneron shares updated data on hearing loss gene therapy

Oct 12, 2025 10:18am
Businessman climbing steps to pluck a star from the sky

Regeneron's ultrarare disease phase 3 hits, teeing up filings

Sep 17, 2025 9:31am
Cat

Regeneron antibodies post ph. 3 wins against cat, pollen allergy

Sep 8, 2025 9:54am
dominoes stop stall halt end red

'Several concerning observations': FDA sheds light on rejections

Sep 5, 2025 10:45am
Focus magnify target strategy

Nykode bets future on cancer trial after losing Genentech pact

Aug 27, 2025 8:25am